查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589052

郁血性心臟衰竭设备市场：按产品、最终用户划分 - 全球预测 2025-2030 年

Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年郁血性心臟衰竭设备市场价值为124.4亿美元，预计到2024年将达到134.4亿美元，复合年增长率为8.16%，到2030年将达到215.4亿美元。

郁血性心臟衰竭(CHF) 治疗设备对于透过促进最佳心臟功能来控制心臟衰竭至关重要。这些设备的需求源于心臟衰竭盛行率的上升、人口老化、技术进步以及心血管健康意识的增强。应用范围从除颤心臟去颤器、心律调节器和辅助人工心臟等植入式设备到心臟再同步治疗设备等非侵入性设备。主要最终用户包括医院、心臟诊所和门诊手术中心，反映了更广泛的医疗保健行业的依赖。影响市场成长的主要因素包括医疗保健支出的增加、老年人口的增加、心血管疾病发生率的增加以及医疗技术的快速进步。最新的机会来自于新兴市场医疗保健基础设施的扩张、用于远端监控的整合无线技术以及提高准确性的人工智慧主导的诊断工具。这些机会表明，进入和拓展对尖端解决方案有很高需求的市场，特别是在医疗保健需求开拓的地区，是非常有益的。然而，高昂的治疗成本、严格的监管要求以及因故障而导致的潜在设备召回等挑战可能会限制市场扩张。患者的接受度和依从性问题，加上缺乏操作先进设备的熟练专业人员，可能会进一步限制某些地区的成长。潜在的创新领域包括开发更具成本效益的设备、提高患者舒适度和依从性，以及透过人工智慧和机器学习专注于个人化治疗。此外，增加与远端医疗和行动医疗应用程式的连接可以简化患者管理并扩大设备覆盖范围。郁血性心臟衰竭设备市场的特点是竞争激烈，领先公司透过创新和策略伙伴关係寻求优势。因此，投资研发以及适用法规的公司可以在这个新兴市场中获得竞争优势。

主要市场统计
基准年[2023] 124.4亿美元
预测年份 [2024] 134.4亿美元
预测年份 [2030] 215.4亿美元
复合年增长率（%） 8.16%

市场动态：快速心臟衰竭的郁血性治疗设备市场的关键市场洞察

郁血性心臟衰竭设备市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助组织做出明智的投资决策、改善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 由于生活方式的改变，心臟衰竭和心律不整的敏感性增加
    • 越来越关注心臟相关疾病的早期初步诊断
    • 政府努力提高人们对心血管疾病的认识
  • 市场限制因素
    • 偏好相对昂贵的设备和药品
  • 市场机会
    • 政府增加对慢性心臟衰竭治疗设备的核准
    • CHF治疗设备的技术进步
  • 市场挑战
    • 严格的监管核准流程

波特五力：开拓郁血性心臟衰竭设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解郁血性心臟衰竭设备市场的外部影响

外部宏观环境因素在塑造郁血性心臟衰竭设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解郁血性心臟衰竭设备市场的竞争格局

对郁血性心臟衰竭设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵郁血性治疗设备市场供应商心臟衰竭评估

FPNV定位矩阵是评估郁血性心臟衰竭器材市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了郁血性心臟衰竭设备市场的成功之路

对郁血性心臟衰竭设备市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活方式的改变增加了心臟衰竭和心律不整的敏感性
      • 重视心臟相关疾病的早期和初步诊断
      • 政府努力提高人们对心血管疾病的认识
    • 抑制因素
      • 偏好相对昂贵的设备和药品
    • 机会
      • 政府增加对 CHF 设备的核准
      • CHF治疗设备的技术进步
    • 任务
      • 严格的监管核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章郁血性心臟衰竭设备市场：副产品

  • 心臟再同步治疗
    • 心臟再同步治疗－心臟去颤器
    • 心臟再同步治疗－心律调节器
  • 植入式心臟整流去颤器
    • 皮下植入式心臟整流去颤器
    • 植入式心臟整流去颤器
  • 心律调节器
  • 辅助人工心臟
    • 双心室辅助装置
    • 左心室辅助装置
    • 右心室辅助装置

第七章郁血性心臟衰竭设备市场：依最终使用者分类

  • 门诊手术中心
  • 医院/诊所

第八章美洲郁血性心臟衰竭设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区郁血性心臟衰竭器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲郁血性心臟衰竭设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • ReliantHeart Inc.
  • St. Jude Medical, Inc.
Product Code: MRR-036CEF508588

The Congestive Heart Failure Treatment Device Market was valued at USD 12.44 billion in 2023, expected to reach USD 13.44 billion in 2024, and is projected to grow at a CAGR of 8.16%, to USD 21.54 billion by 2030.

Congestive heart failure (CHF) treatment devices are pivotal in managing heart failure by facilitating optimal cardiac function. The necessity of these devices arises from the rising prevalence of heart failure, an aging population, technological advancements, and increasing awareness regarding cardiovascular health. Applications range from implantable devices like defibrillators, pacemakers, and ventricular assist devices to non-invasive equipment such as cardiac resynchronization therapy devices. The primary end-users include hospitals, specialized cardiac clinics, and ambulatory surgical centers, reflecting a broad healthcare sector dependency. Key factors influencing market growth include rising healthcare expenditures, growing geriatric population, increasing incidences of cardiovascular diseases, and rapid advancements in medical technology. Latest opportunities arise from expanding healthcare infrastructure in emerging markets, integrated wireless technology for remote monitoring, and AI-driven diagnostic tools enhancing precision. These opportunities suggest entering or expanding in markets with high demand for cutting-edge solutions, particularly in regions with untapped healthcare needs, could be highly beneficial. However, challenges like high treatment costs, stringent regulatory requirements, and potential device recalls due to malfunction can limit market expansion. Acceptability and adherence issues among patients, coupled with lack of skilled professionals in handling advanced devices, can further restrict growth in certain regions. Potential innovation areas include the development of more cost-effective devices, enhancing patient comfort and adherence, and focusing on personalization of treatment via AI and machine learning. Furthermore, increasing connections with telemedicine and mobile health applications could streamline patient management and broaden device applicability. The congestive heart failure treatment device market is characterized by intense competition, with major players seeking dominance through innovations and strategic partnerships. Consequently, businesses investing in research and development, along with adaptive regulations, stand to gain a competitive edge in this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 12.44 billion
Estimated Year [2024] USD 13.44 billion
Forecast Year [2030] USD 21.54 billion
CAGR (%) 8.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Congestive Heart Failure Treatment Device Market

The Congestive Heart Failure Treatment Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
    • Increasing focus on early and primary diagnosis of heart-related disorders
    • Government initiatives spreading awareness on cardiovascular diseases
  • Market Restraints
    • Relatively expensive devices and preference for drugs
  • Market Opportunities
    • Rising government approvals for CHF devices
    • Technological advancements in CHF treatment devices
  • Market Challenges
    • Stringent regulatory approval process

Porter's Five Forces: A Strategic Tool for Navigating the Congestive Heart Failure Treatment Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Congestive Heart Failure Treatment Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Congestive Heart Failure Treatment Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Congestive Heart Failure Treatment Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Congestive Heart Failure Treatment Device Market

A detailed market share analysis in the Congestive Heart Failure Treatment Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Congestive Heart Failure Treatment Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Congestive Heart Failure Treatment Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Congestive Heart Failure Treatment Device Market

A strategic analysis of the Congestive Heart Failure Treatment Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Congestive Heart Failure Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Congestive Heart Failure Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker, and Ventricular Assist Device. The Cardiac Resynchronization Therapy is further studied across Cardiac Resynchronization Therapy-Defibrillator and Cardiac Resynchronization Therapy-Pacemaker. The Implantable Cardioverter Defibrillator is further studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator. The Ventricular Assist Device is further studied across Biventricular Assist Device, Left Ventricular Assist Device, and Right Ventricular Assist Device.
  • Based on End-User, market is studied across Ambulatory Surgery Center and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
      • 5.1.1.2. Increasing focus on early and primary diagnosis of heart-related disorders
      • 5.1.1.3. Government initiatives spreading awareness on cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive devices and preference for drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising government approvals for CHF devices
      • 5.1.3.2. Technological advancements in CHF treatment devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Congestive Heart Failure Treatment Device Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy
    • 6.2.1. Cardiac Resynchronization Therapy-Defibrillator
    • 6.2.2. Cardiac Resynchronization Therapy-Pacemaker
  • 6.3. Implantable Cardioverter Defibrillator
    • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillator
    • 6.3.2. Transvenous Implantable Cardioverter Defibrillator
  • 6.4. Pacemaker
  • 6.5. Ventricular Assist Device
    • 6.5.1. Biventricular Assist Device
    • 6.5.2. Left Ventricular Assist Device
    • 6.5.3. Right Ventricular Assist Device

7. Congestive Heart Failure Treatment Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Center
  • 7.3. Hospitals & Clinics

8. Americas Congestive Heart Failure Treatment Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Congestive Heart Failure Treatment Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Congestive Heart Failure Treatment Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abiomed, Inc.
  • 2. Berlin Heart GmbH
  • 3. Biotronik SE & Co. KG
  • 4. Boston Scientific Corporation
  • 5. HeartWare International, Inc.
  • 6. Jarvik Heart, Inc.
  • 7. LivaNova PLC
  • 8. Medtronic plc
  • 9. ReliantHeart Inc.
  • 10. St. Jude Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023